1. NICE. 2013. Guide to the methods of technology appraisal. NICE, London. https://www.nice.org.uk/guidance/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781. Accessed 2 Apr 2020.
2. Boysen M, Watson I. Reflections on NICE’s uptake of new methods: past, present, and the 2020 review. PharmacoEconomics. 2020;38:243–5. https://doi.org/10.1007/s40273-020-00888-5.
3. DHSC. 2019. The 2019 voluntary scheme for branded medicines pricing and access: chapters and glossary. DHSC, London. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/761834/voluntary-scheme-for-branded-medicines-pricing-and-access-chapters-and-glossary.pdf. Accessed 2 Apr 2020.
4. NICE. 2016. Exploring the assessment and appraisal of regenerative medicines and cell therapy products. NICE, London. https://www.nice.org.uk/Media/Default/About/what-we-do/Science%20policy%20and%20research/Regenerative-medicine-study-march-2016.pdf. Accessed 2 Apr 2020.
5. Marsden G, Towse A. Exploring the assessment and appraisal of regenerative medicines and cell therapy products: is the NICE approach fit for purpose? OHE consulting report. London: Office of Health Economics; 2017.